Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Concussion Assessment, Young Adults and Adults
NCT ID: NCT03249675
Last Updated: 2018-09-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
OBSERVATIONAL
2017-07-05
2019-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluating a Novel Method of EEG Evoked Response Potential Analysis in Sport Concussion Assessment - Test Stability and Effect of Concussion
NCT01535339
A Prospective Study of Brain Network Activation (BNA) Changes in High School Athletes Following Concussion
NCT01673464
Unblinded Data Collection Study of Concussion Using BrainPulse
NCT02992795
Evaluation of an EEG Based Concussion System
NCT03710109
Cortical Plasticity Assessment in Athletes With a History of Concussion
NCT01112761
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
ElMindA, the sponsor of this study, has developed a novel method to automatically reveal functional networks of brain activity based on analysis of EEG Event Related Potential (ERP) data. This technological platform is capable of providing new metrics of brain function which can assist in patient evaluation and management. The analysis is done in two separate processes which are entirely separate and are performed independently of one another. First EEG data are recorded and analyzed from a group, or several groups, of subjects to establish a set of group patterns which characterized the brain network activity of the group. Second, EEG data from a single subject are processed to enable subject evaluation, as compared to the established group patterns. This individual analysis is the basis of the BNA scores computed for an individual subject.
Primary Objective:
• Exploratory (e.g. Hypothesis-generating) study designed to collect data that will aid in future understanding of the relationship between Post Concussion Syndrome and Electrophysiology. The results are primarily intended for scientific inquiry and development purposes.
Additional objectives:
* Exploring the relationship between the characteristics of early/acute stage Mild Traumatic Brain Injury and the subsequent development of PCS
* Collecting electrophysiological and clinical data that will serve as the basis for athlete brain health case studies.
Arm 1: Study staff will contact subjects tested in the past with BNA and were diagnosed with Post-Concussion Syndrome at their medical facility.
Arm 2: Eligible subjects treated at the study medical facility for acute concussion or Post Concussion Syndrome will be approached by the study staff.
Interested volunteers will complete a brief initial in person or phone consultation with a member of the study team and those who meet eligibility criteria and wish to participate will be invited for a study visit in the testing facility. During this visit, a member of the study team will describe the study in greater detail, verify subject eligibility, obtain informed written consent/assent for study participation, and record relevant demographic, medical history information, concussion history and clinical assessment questioners as provided by the subject or as available from subject's medical records. The subject will then have the EEG electrode cap placed on their head and will undergo the BNA test after a brief training and instructional session.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ARM 1
ARM 1: Retrospective Arm: Subjects tested with BNA in the past and have been diagnosed by their physician as having Post Concussive Syndrome. Study staff will contact the subjects and obtain Informed Consent. Study physicians will then review both BNA data and Clinical data. All relevant clinical data and all available BNA data will be shared with ElMindA. Subjects may be invited for an additional BNA follow up as part of the study.
No interventions assigned to this group
ARM 2
ARM 2: Subjects will be prospectively enrolled in the study at the following time points when available:
* Acute: within 2 weeks of injury
* PCS: Subjects which sustained a concussion in the past 3 months or more, and are still experiencing symptoms related to the injury
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to participate in the study and the ability to give informed assent (for children) and/or consent (for the parent of a minor or adults aged 18 years of age or older for themselves).
* Subjects that are or were diagnosed with mTBI according to the standard diagnostic procedures at the investigational site in a timeframe that meets enrollment criteria.
* Subjects that are experiencing symptoms of concussion or Post-concussion Syndrome at the time of their initial test session.
Exclusion Criteria
* Self-reported history of central nervous system injury other than mTBI, or disease (examples will include, but will not be limited to, moderate or severe traumatic brain injury (TBI with a Glasgow Coma Scale \< 13) epilepsy, seizures, brain surgery)
* Neuropsychological disorder such as autistic spectrum disorder
* Any history of a learning disability (examples include, but will not be limited to, dyslexia, dysgraphia, dyscalculia, or a nonverbal learning disorder)
* Use of any medication affecting central nervous system (CNS) in the past 3 months prior to their BNA (i.e. antidepressants, anticonvulsants, psychostimulants, first generation antihistamines, etc.)
* Active head lice infection
* Open scalp wound
* baldness, dread locks or hair that is otherwise sufficiently long and thick so as to preclude appropriate scalp electrode cap fit
* Deafness, and/or blindness
12 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ElMindA Ltd
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffrey Kutcher, MD
Role: PRINCIPAL_INVESTIGATOR
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Sports Neurology Clinic at The CORE Institute
Brighton, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ELM 48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.